David M. Armstrong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
David M. Armstrong has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Alexander Kharlamov
Allegheny University of the Health Sciences, Neurosciences Research Center, Pittsburgh, Pennsylvania, USA
1 shared publicationAlexandr A Alexeev
Institute of Pharmacology, Russian Academy of Medical Sciences, 8 Baltiyskaya Street, 125315 Moscow, Russia
1 shared publication- Anatoliy Fedorovich Vanin
N.N. Semenov Federal Research Center For Chemical Physics Moscow Russia
1 shared publication Elena Kharlamov
Allegheny University of the Health Sciences, Neurosciences Research Center, Pittsburgh, Pennsylvania
1 shared publicationIgor P Ashmarin
Lankenau Institute for Medical Research, Thomas Jefferson University, Wynnewood, PA 19096, USA
1 shared publicationKirill S Rayevsky
Institute of Pharmacology, Russian Academy of Medical Sciences, 8 Baltiyskaya Street, 125315 Moscow, Russia
1 shared publication
Latest Publications
- 5 March 2001
- Published by Elsevier in Brain Research
- Vol. 894 (1) , 145-149
Novel synthetic analogue of ACTH 4–10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia
- 5 March 2001
- Published by Elsevier in Brain Research
- Vol. 894 (1) , 145-149
Novel synthetic analogue of ACTH 4–10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia
- Open Access
- 1 March 2000
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 55 (3) , B135-B141
Age-Dependent Increase in Infarct Volume Following Photochemically Induced Cerebral Infarction: Putative Role of Astroglia
This study demonstrates that the photochemically induced model of stroke is an extremely viable method of inducing cerebral infarction in old animals. The lesions are reproducible both in terms of location and size and compatible with long-term survival of the animal. With this model we demonstrated, one week following surgery, a significantly larger infarct in rats 20 and 24 months of age compared to 4-month-old rats. The older rats also sustained greater neurologic deficits as assessed on a rotarod task. Older rats also were characterized by a glial response that was far less intense than in young animals. While the precise relationship between glia activation and cerebral damage remains to be determined, it would appear that a better understanding of those factors that contribute to the astrocytic response in the aged rat may be of particular benefit in designing therapeutic strategies aimed at reducing the pathologic consequences of cerebral infarction in elderly humans.
- 1 March 2000
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 55 (3) , B135-B141
Open AccessAge-Dependent Increase in Infarct Volume Following Photochemically Induced Cerebral Infarction: Putative Role of Astroglia
This study demonstrates that the photochemically induced model of stroke is an extremely viable method of inducing cerebral infarction in old animals. The lesions are reproducible both in terms of location and size and compatible with long-term survival of the animal. With this model we demonstrated, one week following surgery, a significantly larger infarct in rats 20 and 24 months of age compared to 4-month-old rats. The older rats also sustained greater neurologic deficits as assessed on a rotarod task. Older rats also were characterized by a glial response that was far less intense than in young animals. While the precise relationship between glia activation and cerebral damage remains to be determined, it would appear that a better understanding of those factors that contribute to the astrocytic response in the aged rat may be of particular benefit in designing therapeutic strategies aimed at reducing the pathologic consequences of cerebral infarction in elderly humans.